2021
DOI: 10.1016/j.jacr.2020.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Study of Initial Imaging Selection in Acute Ischemic Stroke Care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
35
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(47 citation statements)
references
References 62 publications
3
35
0
Order By: Relevance
“…Advanced CTAP imaging in acute ischemic stroke patients was shown to be cost-effective in prior work (17). In that study, the cost-effectiveness analysis was performed from a health care perspective.…”
Section: Introductionmentioning
confidence: 99%
“…Advanced CTAP imaging in acute ischemic stroke patients was shown to be cost-effective in prior work (17). In that study, the cost-effectiveness analysis was performed from a health care perspective.…”
Section: Introductionmentioning
confidence: 99%
“…Both intravenous thrombolytic administration and delayed onset-to-arrival times were independently associated with rescanning imaging time delays, while implementing protocols to obtain NCCT and CTAP simultaneously was associated with avoiding the observed time delays associated with rescanning. Considering that this imaging paradigm has been shown to be the most cost-effective imaging strategy for patients with acute ischemic stroke, 38 the current study provides further support for simultaneous NCCT and CTA 6 CTP imaging to minimize time delays to treatment.…”
Section: Discussionmentioning
confidence: 66%
“…Hopyan et al found that multimodal CT, including NCCT, CTA, and CTP, was about 12% more sensitive than NCCT and CTA and about 18% more sensitive than NCCT alone in stroke determination [ 17 ]. Regarding cost-effectiveness, Martinez et al found that comprehensive CT (NCCT, CTA, and CTP at time of presentation) and comprehensive MR (MRI-DWI, MRA, and MRP) had the greatest lifetime quality-adjusted life-years (QALYs) at 4.81 and 4.82, respectively [ 18 ]. When compared with comprehensive CT, the incremental cost-effectiveness ratio of comprehensive MR was $233,000/QALY.…”
Section: Discussionmentioning
confidence: 99%
“…Regarding costeffectiveness,Martinez et al found that comprehensive CT (NCCT, CTA, and CTP at time of presentation) and comprehensive MR (MRI-DWI, MRA, and MRP) had the greatest lifetime quality-adjusted life-years (QALYs) at 4.81 and 4.82, respectively[18]. When compared with comprehensive CT, the incremental costeffectiveness ratio of comprehensive MR was $233,000/QALY.…”
mentioning
confidence: 99%